Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call ... I would now like to introduce Ms. Liz Shea, senior vice president of investor relations. Ma'am, you may begin. Liz Shea-- Senior ...

Welcome to the AbbVie fourth-quarter 2024 Earnings Conference ... I would now like to introduce Ms. Liz Shea, senior vice president of investor relations. Ma'am, you may begin.

Welcome to the AbbVie Fourth Quarter 2024 Earnings Conference ... I would now like to introduce Ms. Liz Shea, Senior Vice President of Investor Relations. Ma'am, you may begin.

Welcome to the AbbVie fourth-quarter 2024 earnings conference call ... I would now like to introduce Ms. Liz Shea, Senior Vice President of Investor Relations. Ma'am, you may begin. Thank you. Good ...

And we like the fit it has for AbbVie. Liz Shea-- Senior Vice President, Investor Relations Thank you, Chris. And that concludes today's conference call. If you'd like to listen to a replay of the ...

"AbbVie is committed to expanding our R&D efforts in oncology ... Xilio explicitly disclaims any obligation to update any forward-looking statements. Vice President, Investor Relations and Corporate ...

Defense Secretary Pete Hegseth has ordered senior military and Defense Department officials to draw up plans to cut 8 percent ...

Company Announcement COPENHAGEN, Denmark; February 12, 2025 - Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2024. Below is a summary of business progress in 2024 ...

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections Inspira announced its bio-electronic ...

Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28 This proposed transaction further diversifies Zimm ...